Table 1.
Clinical features of type 2 diabetes and control groups
| Control subjects | Type 2 diabetes | P | |
| N | 22 | 10 | |
| Age (years) | 61.5 ± 5.5 | 62.2 ± 7.5 | P = 0.76 |
| M:F | 15:7 | 8:2 | |
| Diabetes duration (years) | - | 6.5 (7.75) | |
| BMI (kg/m2) | 26.6 ± 4.5 | 28.1 ± 6.9 | P = 0.46 |
| HbA1c (%) | - | 6.9 ± 0.7 | |
| Systolic blood pressure(mmHg) | 145.8 ± 21.8 | 144.7 ± 16.9 | P = 0.88 |
| Diastolic blood pressure(mmHg) | 89.6 ± 11.3 | 80.1 ± 9.3 | P = 0.03 |
| Statin use (n) | 5 | 9 | P = 0.0005 |
| ACE inhibitors (n) | 2 | 4 | P = 0.05 |
| Aspirin (n) | 3 | 6 | P = 0.01 |
Data are means ± SD or median (interquartile range).
BMI – body Mass Index
HbA1c – glycosylated hemoglobin